Study is also ongoing to define endpoints apart from abstinence for measuring treatment efficacy, such as clinically meaningful reductions in drug use associated with enhancements in health outcomes (95). This kind of changes could lessen the regulatory bar for acquiring FDA acceptance For brand new therapeutics. For instance, exploration has indic